These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 8810265)
1. Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells. MacDonald NJ; Freije JM; Stracke ML; Manrow RE; Steeg PS J Biol Chem; 1996 Oct; 271(41):25107-16. PubMed ID: 8810265 [TBL] [Abstract][Full Text] [Related]
2. Point mutations affecting the oligomeric structure of Nm23-H1 abrogates its inhibitory activity on colonization and invasion of prostate cancer cells. Kim YI; Park S; Jeoung DI; Lee H Biochem Biophys Res Commun; 2003 Jul; 307(2):281-9. PubMed ID: 12859952 [TBL] [Abstract][Full Text] [Related]
3. Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro. Freije JM; Blay P; MacDonald NJ; Manrow RE; Steeg PS J Biol Chem; 1997 Feb; 272(9):5525-32. PubMed ID: 9038158 [TBL] [Abstract][Full Text] [Related]
4. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. Hartsough MT; Morrison DK; Salerno M; Palmieri D; Ouatas T; Mair M; Patrick J; Steeg PS J Biol Chem; 2002 Aug; 277(35):32389-99. PubMed ID: 12105213 [TBL] [Abstract][Full Text] [Related]
5. A nucleoside diphosphate kinase A (nm23-H1) serine 120-->glycine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction. Chang CL; Strahler JR; Thoraval DH; Qian MG; Hinderer R; Hanash SM Oncogene; 1996 Feb; 12(3):659-67. PubMed ID: 8637723 [TBL] [Abstract][Full Text] [Related]
6. A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. Howlett AR; Petersen OW; Steeg PS; Bissell MJ J Natl Cancer Inst; 1994 Dec; 86(24):1838-44. PubMed ID: 7990158 [TBL] [Abstract][Full Text] [Related]
7. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. MacDonald NJ; De la Rosa A; Benedict MA; Freije JM; Krutsch H; Steeg PS J Biol Chem; 1993 Dec; 268(34):25780-9. PubMed ID: 8245015 [TBL] [Abstract][Full Text] [Related]
9. Double mutant P96S/S120G of Nm23-H1 abrogates its NDPK activity and motility-suppressive ability. Zhou Q; Yang X; Zhu D; Ma L; Zhu W; Sun Z; Yang Q Biochem Biophys Res Commun; 2007 May; 356(2):348-53. PubMed ID: 17335772 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory activity of nm23-H1 on invasion and colonization of human prostate carcinoma cells is not mediated by its NDP kinase activity. Lee HY; Lee H Cancer Lett; 1999 Oct; 145(1-2):93-9. PubMed ID: 10530775 [TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis. Negroni A; Venturelli D; Tanno B; Amendola R; Ransac S; Cesi V; Calabretta B; Raschellà G Cell Death Differ; 2000 Sep; 7(9):843-50. PubMed ID: 11042679 [TBL] [Abstract][Full Text] [Related]
12. nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression. Khan MH; Yasuda M; Higashino F; Haque S; Kohgo T; Nakamura M; Shindoh M Am J Pathol; 2001 May; 158(5):1785-91. PubMed ID: 11337376 [TBL] [Abstract][Full Text] [Related]
13. Wild-type NM23-H1, but not its S120 mutants, suppresses desensitization of muscarinic potassium current. Otero AS; Doyle MB; Hartsough MT; Steeg PS Biochim Biophys Acta; 1999 Mar; 1449(2):157-68. PubMed ID: 10082974 [TBL] [Abstract][Full Text] [Related]
14. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Leone A; Flatow U; VanHoutte K; Steeg PS Oncogene; 1993 Sep; 8(9):2325-33. PubMed ID: 8395676 [TBL] [Abstract][Full Text] [Related]
15. MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines. Ouatas T; Clare SE; Hartsough MT; De La Rosa A; Steeg PS Clin Exp Metastasis; 2002; 19(1):35-42. PubMed ID: 11918081 [TBL] [Abstract][Full Text] [Related]
16. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805 [TBL] [Abstract][Full Text] [Related]
17. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells. Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869 [TBL] [Abstract][Full Text] [Related]
18. Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity. Wagner PD; Steeg PS; Vu ND Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9000-5. PubMed ID: 9256424 [TBL] [Abstract][Full Text] [Related]
19. Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity. Zhang Q; McCorkle JR; Novak M; Yang M; Kaetzel DM Int J Cancer; 2011 Jan; 128(1):40-50. PubMed ID: 20209495 [TBL] [Abstract][Full Text] [Related]